Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
Selectivity interaction (Glucose transporter panel CellTiter-Glo Luminescent Cell Viability Assay, Promega)) EUB0000307b SLC2A2
Assay data:1 Active, 1 Tested
SummaryCompounds, ActiveRelated BioAssays by Target
Selectivity interaction (Glucose transporter panel (CellTiter-Glo Luminescent Cell Viability Assay, Promega)) EUB0000251b SLC2A2
Assay data:1 Tested
SummaryRelated BioAssays by Target
Inhibition of the Glucose Transporter (GLUT2, SLC2A2) as assessed by a FRET based flow cytometry assay using a genetically-encoded biosensor for measuring free glucose (FLII12Pglu-700uDelta6) in HEK293 JumpIN TRex SLC2A2 WT-OE cells (PubChem AID: 1794829)
Assay data:4 Tested
Flow cytometry transport assay for SLC2A2 using HEK293 JumpIN TRex SLC2A2 WT-OE cells
Assay data:1 Active, 4 Tested
SummaryCompounds, ActiveRelated BioAssays by DepositorRelated BioAssays by Target
Cell-based assay with CellTiter-Glo readout for ATP production with SLC2A2
Assay data:2 Tested
Inhibition of human GLUT2 expressed in Xenopus laevis oocytes assessed as reduction in [14C]fructose uptake by scintillation spectrometric method
SummaryPubMed CitationRelated BioAssays by Target
Inhibition of human GLUT2 expressed in Xenopus laevis oocytes assessed as reduction in [3H] 2-deoxyglucose uptake by scintillation spectrometric method
Intestinal permeability in ex vivo Wistar rat everted gut sac model assessed as GLUT2-mediated drug permeation by measuring drug level permeated through intestinal membrane at 100 uM added 10 mins after 100 uM SGLT2 inhibitor phloretin and measured after 60 mins post drug dose by HPLC analysis
SummaryCompounds, ActivePubMed CitationRelated BioAssays by Target
Intestinal permeability in ex vivo Wistar rat everted gut sac model assessed as GLUT2-mediated drug permeation by measuring drug level permeated through intestinal membrane at 100 uM added 10 mins after 100 uM SGLT1 inhibitor phloridzin dihydrate and measured after 60 mins post drug dose by HPLC analysis
Intestinal permeability in ex vivo Wistar rat everted gut sac model assessed as GLUT2-mediated drug permeation by measuring drug level permeated through intestinal membrane at 100 uM added 10 mins after 10 uM SGLT1 inhibitor phloridzin dihydrate and measured after 60 mins post drug dose by HPLC analysis
Intestinal permeability in ex vivo Wistar rat everted gut sac model assessed as GLUT2-mediated drug permeation by measuring drug level permeated through intestinal membrane at 100 uM added 10 mins after 100 uM SGLT2 inhibitor phloretin and measured after 30 mins post drug dose by HPLC analysis
Intestinal permeability in ex vivo Wistar rat everted gut sac model assessed as GLUT2-mediated drug permeation by measuring drug level permeated through intestinal membrane at 100 uM added 10 mins after 100 uM SGLT1 inhibitor phloridzin dihydrate and measured after 30 mins post drug dose by HPLC analysis
Intestinal permeability in ex vivo Wistar rat everted gut sac model assessed as GLUT2-mediated drug permeation by measuring drug level permeated through intestinal membrane at 100 uM added 10 mins after 10 uM SGLT1 inhibitor phloridzin dihydrate and measured after 30 mins post drug dose by HPLC analysis
Intestinal permeability in ex vivo Wistar rat everted gut sac model assessed as GLUT2-mediated drug permeation by measuring drug level permeated through intestinal membrane at 100 uM added 10 mins after 100 uM SGLT2 inhibitor phloretin and measured after 15 mins post drug dose by HPLC analysis
Intestinal permeability in ex vivo Wistar rat everted gut sac model assessed as GLUT2-mediated drug permeation by measuring drug level permeated through intestinal membrane at 100 uM added 10 mins after 100 uM SGLT1 inhibitor phloridzin dihydrate and measured after 15 mins post drug dose by HPLC analysis
Intestinal permeability in ex vivo Wistar rat everted gut sac model assessed as GLUT2-mediated drug permeation by measuring drug level permeated through intestinal membrane at 100 uM added 10 mins after 10 uM SGLT1 inhibitor phloridzin dihydrate and measured after 15 mins post drug dose by HPLC analysis
Intestinal permeability in ex vivo Wistar rat everted gut sac model assessed as GLUT2-mediated drug permeation by measuring drug level permeated through intestinal membrane at 100 uM after 60 mins by HPLC analysis
Assay data:4 Active, 5 Tested
Intestinal permeability in ex vivo Wistar rat everted gut sac model assessed as GLUT2-mediated drug permeation by measuring drug level permeated through intestinal membrane at 100 uM after 30 mins by HPLC analysis
Assay data:5 Active, 5 Tested
Intestinal permeability in ex vivo Wistar rat everted gut sac model assessed as GLUT2-mediated drug permeation by measuring drug level permeated through intestinal membrane at 100 uM after 15 mins by HPLC analysis
Assay data:5 Active, 1 Activity ≤ 1 µM, 5 Tested
SummaryCompounds, ActiveCompounds, activity ≤ 1 µMPubMed CitationRelated BioAssays by Target
Inhibition of human GluT2 expressed in HEK293 cells assessed as reduction in 3H]-deoxy-D-glucose uptake incubated for 30 mins by scintillation counting method
Assay data:51 Active, 56 Activity ≤ 1 µM, 356 Tested
SummaryCompounds, ActiveCompounds, activity ≤ 1 µMRelated BioAssays by Target
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on